Supplementary Figure S2 from Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

Authors :: Ahmad A. Tarhini
John M. Kirkwood
Hassane M. Zarour
Amy Rose
Cindy Sander
Matthew P. Holtzman
James F. Pingpank
Christian Laing
Zeni Alfonso
Jennifer Tsau
Anil Pahuja
Ghanashyam Sarikonda
Beiru Chen
Ju Young Kim
Jehovana O. Bender
IlaSri B. Summit
Jennifer Bordeaux
Joseph J. Skitzki
Igor Puzanov
Marc S. Ernstoff
Lisa H. Butterfield
Rogerio I. Neves
Joseph J. Drabick
Arivarasan Karunamurthy
Diwakar Davar
Yan Zang
Yan Lin
Huang Lin
Dustin McCurry
Yana G. Najjar
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Treatment significantly affects the circulating immune compartment.

Tools